A股異動丨同為股份(002835.SZ)跌5.52% 提示二級市場交易風險
格隆匯8月12日丨近10個交易日累漲逾80%的同為股份(002835.SZ)今日下跌5.52%,報22.43元,總市值49億元。同為股份昨日公佈,8月10日、8月11日公司股票連續兩個交易日收盤價格漲幅累計偏離值再次超過20%,再次觸發股票交易異常波動。鑑於近期公司股價剔除大盤整體因素後的實際波動幅度較大,敬請廣大投資者注意二級市場交易風險,審慎投資。公司產品綜合毛利率的紅外測温產品,未來隨着全球市場紅外測温產品產能增加、競爭加大,及各國新冠疫情的變化,能否保持穩定銷售及較高的毛利率存在一定不確定性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.